company background image
300583 logo

Shandong Sito Bio-technology SZSE:300583 Stock Report

Last Price

CN¥20.73

Market Cap

CN¥3.9b

7D

-11.3%

1Y

7.0%

Updated

24 Dec, 2024

Data

Company Financials

Shandong Sito Bio-technology Co., Ltd.

SZSE:300583 Stock Report

Market Cap: CN¥3.9b

300583 Stock Overview

Researches, develops, and produces steroid biomedicine intermediates. More details

300583 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Shandong Sito Bio-technology Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shandong Sito Bio-technology
Historical stock prices
Current Share PriceCN¥20.73
52 Week HighCN¥31.63
52 Week LowCN¥10.66
Beta0.19
1 Month Change-16.11%
3 Month Change35.40%
1 Year Change6.97%
3 Year Change40.07%
5 Year Change-3.36%
Change since IPO-42.83%

Recent News & Updates

We Think Shandong Sito Bio-technology (SZSE:300583) Is Taking Some Risk With Its Debt

Dec 24
We Think Shandong Sito Bio-technology (SZSE:300583) Is Taking Some Risk With Its Debt

There's Reason For Concern Over Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) Massive 26% Price Jump

Nov 15
There's Reason For Concern Over Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) Massive 26% Price Jump

Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 33% Share Price Surge Not Quite Adding Up

Sep 27
Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 33% Share Price Surge Not Quite Adding Up

Recent updates

We Think Shandong Sito Bio-technology (SZSE:300583) Is Taking Some Risk With Its Debt

Dec 24
We Think Shandong Sito Bio-technology (SZSE:300583) Is Taking Some Risk With Its Debt

There's Reason For Concern Over Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) Massive 26% Price Jump

Nov 15
There's Reason For Concern Over Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) Massive 26% Price Jump

Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 33% Share Price Surge Not Quite Adding Up

Sep 27
Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 33% Share Price Surge Not Quite Adding Up

Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge

Jun 06
Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge

There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings

May 05
There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings

Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%

Apr 16
Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%

Shareholder Returns

300583CN PharmaceuticalsCN Market
7D-11.3%-3.1%-2.1%
1Y7.0%-4.4%9.8%

Return vs Industry: 300583 exceeded the CN Pharmaceuticals industry which returned -4.4% over the past year.

Return vs Market: 300583 underperformed the CN Market which returned 9.8% over the past year.

Price Volatility

Is 300583's price volatile compared to industry and market?
300583 volatility
300583 Average Weekly Movement13.0%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300583's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300583's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20021,200Lianbiao Jinwww.sitobiotech.com

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. The company was founded in 2002 and is based in Heze City, China.

Shandong Sito Bio-technology Co., Ltd. Fundamentals Summary

How do Shandong Sito Bio-technology's earnings and revenue compare to its market cap?
300583 fundamental statistics
Market capCN¥3.93b
Earnings (TTM)-CN¥838.17k
Revenue (TTM)CN¥1.12b

3.5x

P/S Ratio

-4,692x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300583 income statement (TTM)
RevenueCN¥1.12b
Cost of RevenueCN¥889.88m
Gross ProfitCN¥231.72m
Other ExpensesCN¥232.55m
Earnings-CN¥838.17k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0044
Gross Margin20.66%
Net Profit Margin-0.075%
Debt/Equity Ratio34.5%

How did 300583 perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

-10,186%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 19:02
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Sito Bio-technology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ban WangMinsheng Securities Co.